Clinical Trials Browser

Interventional × Neoplasm Recurrence, Local × Bevacizumab × Clear all

NCT00095225 2008-01-29

A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer)

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Neoplasm Recurrence, Local, Recurrence